Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-17-001519
Filing Date
2017-09-20
Accepted
2017-09-20 16:32:07
Documents
1
Period of Report
2017-09-19

Document Format Files

Seq Description Document Type Size
1 form4-09202017_010956.html 4  
1 form4-09202017_010956.xml 4 4075
  Complete submission text file 0001415889-17-001519.txt   5524
Mailing Address 5 CENTERPOINTE DRIVE SUITE 400 LAKE OSWEGO OR 97035
Business Address
DOTSON JERROLD DUANE (Reporting) CIK: 0001388853 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37761 | Film No.: 171094287

Mailing Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-577-3600
VistaGen Therapeutics, Inc. (Issuer) CIK: 0001411685 (see all company filings)

EIN.: 205093315 | State of Incorp.: NV | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations